A promoter polymorphism in the hMLH1 gene (-93G/A) associated with sporadic colorectal cancer

Zhang,Li‑Li; Tang,Xue‑Jun; Wang,Xiao‑Yun; Zhu,Ying‑Wei; Peng,Xiao‑Bin; Gong,Lei

doi:10.3892/ol.2016.5188

A promoter polymorphism in the hMLH1 gene (-93G/A) associated with sporadic colorectal cancer

Authors:
- Li‑Li Zhang
- Xue‑Jun Tang
- Xiao‑Yun Wang
- Ying‑Wei Zhu
- Xiao‑Bin Peng
- Lei Gong
View Affiliations

Affiliations: Department of Gastroenterology, Wuxi No. 2 People's Hospital, Wuxi, Jiangsu 214000, P.R. China
Published online on: September 26, 2016 https://doi.org/10.3892/ol.2016.5188
Pages: 4035-4040

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Colorectal cancer (CRC) is a worldwide problem for public health. mutL homolog 1 (MLH1) is a key component of the mismatch repair system, and the MLH1‑93G/A polymorphism (rs1800734) is predicted to affect MLH1 protein expression, suggesting that the polymorphism may be associated with the cancer risk; however, the results concerning this have been inconsistent. In order to investigate the possible correlation between human (h)MLH1‑93G/A polymorphism and the development and progression of sporadic CRC (SCRC) in China, the genotypes of hMLH1‑93G/A were detected by the TaqMan MGB probe method in 312 SCRC patients and 300 healthy controls, and immunohistochemical staining was also performed to measure the expression of hMLH1 in cases with different alleles among the SCRC patients and normal controls. It was observed that the A/A genotype and A allele significantly increased the risk of developing Duke's stage C+D CRC and lymphatic metastasis. hMLH1 expression of the A allele was lower than that of the G allele in CRC. By contrast, there was no statistically significant difference in hMLH1 expression for the A allele and the G allele in the normal controls. These results suggested that hMLH1‑93G/A polymorphism may not be associated with the overall risk of CRC, but that the hMLH1‑93A/A genotype and A allele are associated with the progression of CRC.

View Figures

View References

1	Fengju S, Guanglin W and Kexin C: Incidence of colon cancer in Tianjin, China, 1981ߝ2000. Asia Pac J Public Health. 17:22–25. 2005. View Article : Google Scholar : PubMed/NCBI
2	de la Chapelle A: Genetic predisposition to colorectal cancer. Nat Rev Cancer. 4:769–780. 2004. View Article : Google Scholar : PubMed/NCBI
3	Kunkel TA and Erie DA: DNA mismatch repair. Annu Rev Biochem. 74:681–710. 2005. View Article : Google Scholar : PubMed/NCBI
4	Lipkin SM, Rozek LS, Rennert G, Yang W, Chen PC, Hacia J, Hunt N, Shin B, Fodor S, Kokoris M, et al: The MLH1 D132H variant is associated with susceptibility to sporadic colorectal cancer. Nat Genet. 36:694–699. 2004. View Article : Google Scholar : PubMed/NCBI
5	Fearnhead NS, Wilding JL, Winney B, Tonks S, Bartlett S, Bicknell DC, Tomlinson IP, Mortensen NJ and Bodmer WF: Multiple rare variants in different genes account for multifactorial inherited susceptibility to colorectal adenomas. Proc Natl Acad Sci USA. 101:15992–15997. 2004. View Article : Google Scholar : PubMed/NCBI
6	Tomlinson IP, Webb E, Carvajal-Carmona L, Broderick P, Howarth K, Pittman AM, Spain S, Lubbe S, Walther A, Sullivan K, et al: A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3. Nat Genet. 40:623–630. 2008. View Article : Google Scholar : PubMed/NCBI
7	Christmann M, Tomicic MT, Roos WP and Kaina B: Mechanisms of human DNA repair: An update. Toxicology. 193:3–34. 2003. View Article : Google Scholar : PubMed/NCBI
8	Lynch HT and de la Chapelle A: Hereditary colorectal cancer. N Engl J Med. 348:919–932. 2003. View Article : Google Scholar : PubMed/NCBI
9	Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, Kuebler P, Nakagawa H, Sotamaa K, Prior TW, Westman J, et al: Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med. 352:1851–1860. 2005. View Article : Google Scholar : PubMed/NCBI
10	Ito E, Yanagisawa Y, Iwahashi Y, Suzuki Y, Nagasaki H, Akiyama Y, Sugano S, Yuasa Y and Maruyama K: A core promoter and a frequent single-nucleotide polymorphism of the mismatch repair gene hMLH1. Biochem Biophys Res Commun. 256:488–494. 1999. View Article : Google Scholar : PubMed/NCBI
11	Arita M, Zhong X, Min Z, Hemmi H and Shimatake H: Multiple sites required for expression in 5′-flanking region of the hMLH1 gene. Gene. 306:57–65. 2003. View Article : Google Scholar : PubMed/NCBI
12	Simpkins SB, Bocker T, Swisher EM, Mutch DG, Gersell DJ, Kovatich AJ, Palazzo JP, Fishel R and Goodfellow PJ: MLH1 promoter methylation and gene silencing is the primary cause of microsatellite instability in sporadic endometrial cancers. Hum Mol Genet. 8:661–666. 1999. View Article : Google Scholar : PubMed/NCBI
13	Zou XP, Dai WJ and Cao J: CDH1 promoter polymorphism (−347G->GA) is a possible prognostic factor in sporadic colorectal cancer. World J Gastroenterol. 15:5340–5345. 2009. View Article : Google Scholar : PubMed/NCBI
14	Mei Q, Yan HL, Ding FX, Xue G, Huang JJ, Wang YZ and Sun SH: Single-nucleotide polymorphisms of mismatch repair genes in healthy Chinese individuals and sporadic colorectal cancer patients. Cancer Genet Cytogenet. 171:17–23. 2006. View Article : Google Scholar : PubMed/NCBI
15	Campbell PT, Curtin K, Ulrich CM, Samowitz WS, Bigler J, Velicer CM, Caan B, Potter JD and Slattery ML: Mismatch repair polymorphisms and risk of colon cancer, tumour microsatellite instability and interactions with lifestyle factors. Gut. 58:661–667. 2009. View Article : Google Scholar : PubMed/NCBI
16	Park SH, Lee GY, Jeon HS, Lee SJ, Kim KM, Jang SS, Kim CH, Lee WK, Kam S, Park RW, et al: -93G->A polymorphism of hMLH1 and risk of primary lung cancer. Int J Cancer. 112:678–682. 2004. View Article : Google Scholar : PubMed/NCBI
17	Lo YL, Hsiao CF, Jou YS, Chang GC, Tsai YH, Su WC, Chen KY, Chen YM, Huang MS, Hsieh WS, et al: Polymorphisms of MLH1 and MSH2 genes and the risk of lung cancer among never smokers. Lung Cancer. 72:280–286. 2011. View Article : Google Scholar : PubMed/NCBI
18	Allan JM, Shorto J, Adlard J, Bury J, Coggins R, George R, Katory M, Quirke P, Richman S, Scott D, et al: MLH1-93G>A promoter polymorphism and risk of mismatch repair deficient colorectal cancer. Int J Cancer. 123:2456–2459. 2008. View Article : Google Scholar : PubMed/NCBI
19	Raptis S, Mrkonjic M, Green RC, Pethe VV, Monga N, Chan YM, Daftary D, Dicks E, Younghusband BH, Parfrey PS, et al: MLH1-93G>A promoter polymorphism and the risk of microsatellite-unstable colorectal cancer. J Natl Cancer Inst. 99:463–474. 2007. View Article : Google Scholar : PubMed/NCBI
20	Chen H, Taylor NP, Sotamaa KM, Mutch DG, Powell MA, Schmidt AP, Feng S, Hampel HL, de la Chapelle A and Goodfellow PJ: Evidence for heritable predisposition to epigenetic silencing of MLH1. Int J Cancer. 120:1684–1688. 2007. View Article : Google Scholar : PubMed/NCBI
21	Brenner C, Deplus R, Didelot C, Loriot A, Viré E, De Smet C, Gutierrez A, Danovi D, Bernard D, Boon T, et al: Myc represses transcription through recruitment of DNA methyltransferase corepressor. EMBO J. 24:336–346. 2005. View Article : Google Scholar : PubMed/NCBI
22	Brenner C and Fuks F: DNA methyltransferases: Facts, clues, mysteries. Curr Top Microbiol Immunol. 301:45–66. 2006.PubMed/NCBI